Crossmark

Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Crossref DOI link: https://doi.org/10.1007/s13340-020-00436-8

Published Online: 2020-04-23

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Komatsu, Hitomi

Enomoto, Mariko

Shiraishi, Hisashi

Morita, Yasuyo

Hashimoto, Daisuke

Nakayama, Shuichi

Funakoshi, Shogo

Hirano, Seiki

Terada, Yoshio

Miyamura, Mitsuhiko

Fujimoto, Shimpei
License Information

Text and Data Mining valid from 2020-04-23

Version of Record valid from 2020-04-23
More Information

Article History

First Online: 23 April 2020

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below